Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- PLN 20.49T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | PLN 40B | PLN 264.89 | 5.09% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | PLN 33.1B | PLN 477.72 | 1.92% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | PLN 19.7B | PLN 349.75 | 0.03% up | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | PLN 32.9B | PLN 504.14 | 0.60% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | PLN 34.5B | PLN 1,234.03 | 0.64% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | PLN 29B | PLN 207.98 | 0.17% up | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | PLN 18.4B | PLN 110.46 | 1.93% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | PLN 24.2B | PLN 1,208.73 | 2.35% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | PLN 36.9B | PLN 388.10 | 2.92% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | PLN 31.7B | PLN 188.36 | 3.10% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | PLN 18.4B | PLN 168.28 | 0.42% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | PLN 61.2B | PLN 314.04 | 1.73% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | PLN 18.7B | PLN 53.22 | 4.68% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | PLN 19.6B | PLN 112.87 | 0.83% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | PLN 24.3B | PLN 371.98 | 0.64% up | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | PLN 19.7B | PLN 204.98 | 0.21% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | PLN 26.4B | PLN 389.22 | 0.53% up | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | PLN 20.3B | PLN 242.67 | 0.02% up | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | PLN 37.9B | PLN 1,632.18 | 3.78% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | PLN 63.5B | PLN 989.84 | 2.30% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | PLN 30B | PLN 274.30 | 2.61% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | PLN 24.7B | PLN 174.94 | 1.23% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | PLN 21B | PLN 498.16 | 1.36% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | PLN 47.2B | PLN 243.55 | 3.55% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | PLN 15.9B | PLN 116.21 | 1.60% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | PLN 54.1B | PLN 108.31 | 4.24% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | PLN 106.6B | PLN 485.90 | 0.80% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | PLN 112.2B | PLN 154.92 | 0.44% down | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | PLN 28.2B | PLN 536.56 | 1.81% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | PLN 12.7B | PLN 65.28 | 0.81% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | PLN 30B | PLN 381.92 | 0.10% down | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | PLN 34.1B | PLN 42.61 | 0.66% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | PLN 29.5B | PLN 336.60 | 1.99% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | PLN 71.7B | PLN 1,093.22 | 0.29% up | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | PLN 99.6B | PLN 2,339.44 | 0.36% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | PLN 139.1B | PLN 342.25 | 1.99% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | PLN 81.3B | PLN 606.85 | 3.53% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | PLN 25.8B | PLN 635.23 | 0.20% up | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | PLN 30.9B | PLN 88.59 | 4.36% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | PLN 95.3B | PLN 83.11 | 1.10% up | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | PLN 50.4B | PLN 60.44 | 1.66% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | PLN 198B | PLN 169.67 | 0.96% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | PLN 646.6B | PLN 113.43 | 0.88% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | PLN 494.4B | PLN 241.88 | 1.92% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | PLN 160.2B | PLN 278.64 | 0.93% up | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | PLN 394.4B | PLN 3,812.36 | 0.97% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | PLN 548.3B | PLN 2,162.49 | 0.71% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | PLN 127.6B | PLN 207.01 | 0.88% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | PLN 186.2B | PLN 1,629.89 | 1.88% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | PLN 729.4B | PLN 421.14 | 0.06% up | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | PLN 1.38T | PLN 558.75 | 3.04% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | PLN 2.05T | PLN 1,158.87 | 1.54% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | PLN 23.2B | PLN 34.05 | 1.85% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | PLN 702.5B | PLN 159.40 | 2.57% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | PLN 5T | PLN 5,610.59 | 1.40% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | PLN 393.8B | PLN 196.46 | 0.74% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | PLN 2.67T | PLN 1,110.03 | 0.91% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | PLN 457.4B | PLN 190.47 | 0.31% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | PLN 1.19T | PLN 627.71 | 1.87% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | PLN 1.12T | PLN 722.77 | 1.35% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | PLN 275B | PLN 86.08 | 1.04% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0197 PLN).
Questions and answers
Which pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of PLN 20.49T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.